MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-12-2026
Health Catalyst Cash and Cash Equivalents 2011-2026 | HCAT
Annual Cash and Cash Equivalents Health Catalyst
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.8 M | 250 M | 106 M | 116 M | 193 M | 92 M | 18 M | 28.4 M | 23 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 250 M | 18 M | 97.5 M |
Quarterly Cash and Cash Equivalents Health Catalyst
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.3 M | 50.7 M | 342 M | 250 M | 328 M | 202 M | 201 M | 95 M | 116 M | 124 M | - | 198 M | 193 M | 276 M | 205 M | 133 M | 92 M | 92 M | 92 M | 92 M | 18 M | 18 M | 18 M | 18 M | 28.4 M | 28.4 M | 28.4 M | - | 23 M | - | - | - | 12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 342 M | 12.5 M | 118 M |
Cash and Cash Equivalents of other stocks in the Health information services industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
434 M | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
616 M | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
3.85 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
183 M | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
113 M | - | - | $ 9.03 B | USA |
 |
HealthEquity
HQY
|
319 M | $ 86.33 | 0.34 % | $ 7.44 B | USA |
 |
iCAD
ICAD
|
17.2 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
188 M | $ 2.93 | 3.17 % | $ 275 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
188 M | - | -10.39 % | $ 886 M | USA |
 |
GoodRx Holdings
GDRX
|
448 M | $ 2.37 | 4.41 % | $ 914 M | USA |
 |
Akerna Corp.
KERN
|
3.82 M | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
3.12 M | - | -0.58 % | $ 51.7 M | USA |
 |
NextGen Healthcare
NXGN
|
73.3 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
342 M | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
13.9 M | $ 7.2 | 0.42 % | $ 123 M | USA |
 |
Premier
PINC
|
83.7 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
231 M | $ 12.8 | 3.73 % | $ 940 M | USA |
 |
Phreesia
PHR
|
73.8 M | $ 9.43 | 2.84 % | $ 563 M | USA |
 |
R1 RCM
RCM
|
130 M | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
781 M | $ 6.1 | 7.21 % | $ 1.07 B | USA |
 |
10x Genomics
TXG
|
359 M | $ 24.59 | -5.71 % | $ 2.88 B | USA |
 |
Signify Health
SGFY
|
466 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
2.18 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
1.76 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
1.64 M | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
182 M | $ 6.61 | 8.01 % | $ 106 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
70 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
59.5 M | $ 21.34 | -1.79 % | $ 648 M | USA |
 |
Omnicell
OMCL
|
369 M | $ 37.8 | -1.25 % | $ 1.74 B | USA |
 |
Progyny
PGNY
|
162 M | $ 18.64 | 2.87 % | $ 1.6 B | USA |
 |
So-Young International
SY
|
1.13 B | $ 2.9 | 2.47 % | $ 230 M |  China |
 |
Veeva Systems
VEEV
|
1.42 B | $ 168.84 | 0.53 % | $ 27.6 B | USA |
 |
Zhongchao
ZCMD
|
15.1 M | $ 2.06 | - | $ 7.04 M | China |